AIDS
Conditions
Interventions
Sponsors
Tianjin Second People Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Continuous antiviral treatment > 24 months; 2. PlasmaViral load (HIV-1 RNA) was lower than 20 CP/ml when screening; 3. The number of CD 4+ T cells in the peripheral blood was less than 200 cells/ul during antiviral treatment; 4. The patients should have no tumors and no active opportunistic infection (AIDS III and IV symptoms) at least 4 weeks; 5. The patients should be informed consent and comply with the requirement by this study; 6. The patients should not participate in other studies within 6 months.
Exclusion criteria
Exclusion criteria: 1. With other serious disease such as urinary, circulation, respiration, nerve, spirit, digestive, endocrine, immune system disease or tumor; 2. Pregnancy or lactation, including taking no effective contraceptive measures when possible pregnant; 3. Allergic to blood products or other test products; 4. Drug addiction in one year before the test; 5. Low complianace ; unable or unwilling to provide informed consent or failure to comply with the research requirements; 6. The conditions that interfere with clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CD4+ T cell number; | — |
Secondary
| Measure | Time frame |
|---|---|
| CD4/CD8 T cell ratio;Cytokine concentration monitoring;Plasma viral load (HIV-1 RNA) assay; | — |
Countries
China
Contacts
Public ContactPing Ma
Tianjin Second People Hospital
Outcome results
None listed